Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Touchstone invests £1.4m in Featurespace round

4 Oct 2017 07:00

RNS Number : 6116S
Touchstone Innovations PLC
04 October 2017
 

 

4 October 2017

 

Touchstone Innovations plc

 

Touchstone invests £1.4m in £16.5m funding round in Featurespace, the machine learning fraud prevention company

 

Touchstone Innovations plc (AIM: IVO, 'the Group', 'Touchstone') has participated in a £16.5m funding round in Featurespace Limited ("Featurespace" or "the Company"), a leading machine-learning, fraud prevention company.

 

Touchstone has committed £1.4 million to the round, which was led by Highland Europe. The round was also supported by Worldpay Group plc, a leading global payment processing company, and Invoke Capital, a technology investment company. The new funding will enable Featurespace to drive revenues of its product platform and to continue to expand internationally.

 

Following this new investment, Touchstone will hold a 27.9% interest in the Company. The current valuation, including this investment is £15.6 million.

 

Featurespace, based in Cambridge, is an Adaptive Behavioural Analytics company that is addressing the fast-growing fraud detection and prevention market. According to MarketsandMarkets, this market was worth $14.8bn in 2014 and is growing at 18% per annum.

 

The Company has developed a machine learning software platform, ARIC, that identifies abnormal behaviour in high-volume, real-time customer interactions. Through analysing every individual customer interaction and understanding normal behaviour, Featurespace helps to protect customers from fraud attack, and reduces the costs of lost transactions.

 

Featurespace has developed an ambitious growth plan, which focuses on expanding further within the UK and the USA. The business recently opened offices in North Carolina and New York, and last year signed a deal with TSYS, one of the largest payments processors in the US, in which Featurespace's adaptive behavioural analytics platform is being used to reduce fraud for TSYS' clients. The injection of new capital from this funding round will enable the Company to pursue further sales through this channel as well as direct sales to new customers in both existing and new markets.

 

Martina King, CEO of Featurespace, said:

"We are working with our clients to protect businesses and consumers in the fight against fraud. This funding round will enable us to continue to grow our business internationally, building on our progress as a leader in machine learning fraud prevention."

Jon Edington, Director of Technology Ventures at Touchstone Innovations, added:

 

"Featurespace is a business with world-class machine-learning technology married to a management team with an excellent track record, and has the potential to be a substantial international entity.

 

"The evolution and development of Featurespace is a classic example of our approach.

 

"We initially worked with the late Professor Bill Fitzgerald who was head of signal processing and applied statistics at the University of Cambridge and Dave Excell, his PhD student, to develop the technology and concept and made our initial investment into the Company in 2012.

"Subsequently, we have continued to support the business with further funding as well as helping to recruit the management team with the right expertise and experience.

 

"More recently we have sought to build a strong syndicate around the business, widening the pool of investors and bringing in industry expertise.

 

"Today's news reflects the growing maturity of the business and its potential for growth."

 

-Ends-

 

For further information contact:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

 

Jon Davies, Director of Communications

 

 

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

 

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

About Touchstone Innovations - www.touchstoneinnovations.com

 

Touchstone Innovations plc ("Touchstone" formerly Imperial Innovations Group plc) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the Golden Triangle, the region broadly bounded by London, Cambridge and Oxford.

 

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Touchstone supports scientists and entrepreneurs in the commercialisation of their ideas through protecting and licensing out intellectual property (through its Technology Transfer subsidiary, Imperial Innovations Limited), by leading the formation of new companies, by recruiting high-calibre management teams and by providing investment and encouraging co-investment. Touchstone remains an active investor over the life of its portfolio companies, with the majority of Touchstone's investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Touchstone has raised more than £440.0 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has a £74.4 million term debt facility from the European Investment Bank (EIB).

 

Between Touchstone's admission to AIM (August 2006) and 31 July 2017, Touchstone has invested a total of £372.4 million across its portfolio companies, currently valued at £461.1 million and in addition has generated £51.0 million of cash realisations. In aggregate, Touchstone's portfolio, excluding Apollo Therapeutics and UCL Technology Fund, has collectively raised investment of more than £1.7 billion.

 

 

About Featurespace - www.featurespace.co.uk

 

Featurespace™ is the world-leader in Adaptive Behavioral Analytics and creator of the ARIC™ platform, a real-time machine learning software system developed out of the University of Cambridge.

 

The ARIC™ platform - a real-time, machine learning software system - monitors individual behaviors to catch new fraud attacks as they happen. At the same time, the increased accuracy of understanding customer behavior reduces the number of genuine customers whose purchases and transactions are incorrectly declined.

 

Featurespace is based in Cambridge, UK, and the Company has deployed ARIC™ to organizations that have services or products deployed in over 180 countries.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSUFMDFWSEFS
Date   Source Headline
28th Jul 20157:01 amRNS£1 million seed investment in Inflowmatix
27th Jul 20157:00 amRNS£3.0 million investment in Concirrus
23rd Jul 20151:35 pmRNSDirectorate Change
14th Jul 20157:00 amRNSFurther £50m loan facility from EIB
2nd Jul 20157:00 amRNS£4.0m funding round in Impression Technologies
1st Jul 20157:00 amRNSFirst subject enrolled in Veryan Medical's study
30th Jun 20157:00 amRNSLeads £3 million investment in Abingdon Health
8th Jun 20151:18 pmRNSDirectorate Change
3rd Jun 20157:00 amRNSInnovations leads £6m funding round in Auspherix
29th May 20157:00 amRNSAppointment of Executive Chairman at Kesios
27th May 20154:05 pmRNSHolding(s) in Company
26th May 20157:01 amRNSDivests its shares of Epigeum
19th May 20157:00 amRNS£25m Series C funding round in PsiOxus
14th May 20157:00 amRNSTopiVert starts Phase I Clinical Trial
30th Apr 20153:48 pmRNSDirector's share purchase
27th Apr 20157:00 amRNSAutifony Therapeutics recruits first trial patient
15th Apr 20157:00 amRNSInnovations leads £5.9m funding round in Yoyo
27th Mar 20157:00 amRNSHalf Yearly Report
24th Mar 20154:40 pmRNSSecond Price Monitoring Extn
24th Mar 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20157:00 amRNSCell Medica granted Orphan Drug designation
13th Mar 201510:07 amRNSEdison publishes research on Imperial Innovations
27th Feb 201511:48 amRNSNotice of Results
19th Feb 20157:00 amRNSCell Medica to commence cell therapy manufacture
14th Jan 201512:13 pmRNS£18 million Series B funding round in Veryan
18th Dec 20147:00 amRNSImperial named UK's top research university
16th Dec 201411:39 amRNSResult of AGM
9th Dec 20142:55 pmRNSGrant of options under SAYE Scheme
26th Nov 20143:41 pmRNSGrant of share options
25th Nov 201410:45 amRNSReplacement Director's share purchase
25th Nov 20147:00 amRNS£50 million Series B funding round in Cell Medica
24th Nov 20144:20 pmRNSDirector's share sale
12th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
24th Oct 20147:00 amRNSDirectorate Changes
15th Oct 20147:00 amRNSFinal Results
8th Oct 20147:00 amRNSInnovations invests £1.85m in Kesios Therapeutics
5th Sep 20141:55 pmRNSNotice of Results
13th Aug 201412:43 pmRNSDirector's share sale
15th Jul 20142:08 pmRNSDirectorate Change
7th Jul 20147:14 amRNSPortfolio company Abzena announces offer price
4th Jul 20143:36 pmRNSHolding(s) in Company
23rd Jun 20143:15 pmRNSResults of Placing
23rd Jun 20147:00 amRNSPlacing to raise £150 million
19th Jun 201412:45 pmRNSResult of General Meeting
16th Jun 20147:09 amRNSPortfolio company announces intention to float
12th Jun 20147:00 amRNSImperial Innovations invests £1.5m in Cortexica
10th Jun 20147:00 amRNS£3 million funding round for Featurespace
4th Jun 20147:00 amRNSAutifony receives funding for Phase II trial
2nd Jun 20147:00 amRNSAppointment of non-executive directors
2nd Jun 20147:00 amRNSProposed Placing to raise up to £150 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.